Skip to main content

Milestone 6.G

Initiate Phase III drug trials for agents against at least 3 novel therapeutic targets. These trials will incorporate a combination of biomarkers (fluid and imaging) and cognitive measures as outcomes and include the collection of DNA and other bio-samples for the interrogation of responsiveness.


Success Criteria

  • Comprehensive success/failure analysis of data from at least 3 phase III trials.


Research Implementation Area
Drug Development - Novel Targets
Timeline
2022–2026
Status
To Be Initiated

Implementation Activities

Funding Initiatives

Research Programs and Resources

Relevant Recommendations